Skip to main content
This website uses cookies to ensure you get the best experience. By continuing to use this site, you agree to the use of cookies.

Please note: Your browser does not support the features used on Addgene's website. You may not be able to create an account or request plasmids through this website until you upgrade your browser. Learn more

Please note: Your browser does not fully support some of the features used on Addgene's website. If you run into any problems registering, depositing, or ordering please contact us at [email protected]. Learn more

Addgene

AKR7A2 Citations (3)

Originally described in: SGC+year
unpublished

Articles Citing AKR7A2

Articles
Inhibition of human anthracycline reductases by emodin - A possible remedy for anthracycline resistance. Hintzpeter J, Seliger JM, Hofman J, Martin HJ, Wsol V, Maser E. Toxicol Appl Pharmacol. 2016 Jan 7;293:21-29. doi: 10.1016/j.taap.2016.01.003. PubMed
Indirect DNA Sequence Recognition and Its Impact on Nuclease Cleavage Activity. Lambert AR, Hallinan JP, Shen BW, Chik JK, Bolduc JM, Kulshina N, Robins LI, Kaiser BK, Jarjour J, Havens K, Scharenberg AM, Stoddard BL. Structure. 2016 Jun 7;24(6):862-73. doi: 10.1016/j.str.2016.03.024. Epub 2016 Apr 28. PubMed
Roscovitine and purvalanol A effectively reverse anthracycline resistance mediated by the activity of aldo-keto reductase 1C3 (AKR1C3): A promising therapeutic target for cancer treatment. Novotna E, Bukum N, Hofman J, Flaxova M, Kouklikova E, Louvarova D, Wsol V. Biochem Pharmacol. 2018 Oct;156:22-31. doi: 10.1016/j.bcp.2018.08.001. Epub 2018 Aug 3. PubMed

If you have published an article using this material, please email us at [email protected] to have your article added to this page.